Clinical Trials Directory
Recruiting
Conditions
Sponsors
Search
About
Trials
/
Sponsors
/ Entero Therapeutics
Entero Therapeutics
Industry · 10 registered clinical trials.
Status
Trial
Phase
Started
Completed
Study to Assess an Enteric Microgranule Formulation of Adrulipase in Patients With Cystic Fibrosis
Exocrine Pancreatic Insufficiency, Cystic Fibrosis
Phase 2
2023-02-01
Withdrawn
Niclosamide In Moderate COVID-19
COVID
Phase 2
2022-01-20
Withdrawn
Niclosamide in COVID-19
Covid19
Phase 2
2022-01-20
Terminated
Safety and Efficacy of Niclosamide in Patients With COVID-19 With Gastrointestinal Infection
Covid19
Phase 2
2021-04-30
Terminated
Study of Latiglutenase in T1D/CD Patients
Celiac Disease
Phase 2
2021-04-06
Completed
OPTION 2: A Trial to Assess the Safety and Efficacy of MS1819 in Enteric Capsules in Patients With Cystic Fibr
Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF)
Phase 2
2020-07-20
Terminated
Prospective, Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Symptomatic CD Patients
Celiac Disease
Phase 2
2019-11-01
Completed
OPTION: A Trial to Assess the Safety & Efficacy of MS1819 in Patients With Exocrine Pancreatic Insufficiency D
Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF)
Phase 2
2019-01-10
Terminated
A Study of Niclosamide Enemas in Subjects With Active Ulcerative Proctitis or Ulcerative Proctosigmoiditis
Ulcerative Colitis, Ulcerative Proctitis, Ulcerative Proctosigmoiditis
Phase 1 / Phase 2
2018-05-15
Completed
Simvastatin Metabolism as a Test for CD Activity (IRB 15-007568]
Celiac Disease
EARLY_Phase 1
2016-03-01